Trials
Search / Trial NCT06440564

Laser Disinfection in Periprosthetic Joint Infection

Launched by MEDICAL UNIVERSITY OF VIENNA · May 31, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Enrolling by invitation

Keywords

Er:Yag Laser Biofilm Removal Periprosthetic Joint Infections (Pji) Dair Laser Disinfection

ClinConnect Summary

Infections after joint arthroplasties represent a devastating and progressively escalating complication with increased morbidity and mortality. The eradication of biofilms from infected implants is still an unsolved challenge. The high-energy light beam of an Er:YAG laser causes rapid heating and explosive ablation of tissue. In this study the investigators test the suitability of this laser for the removal of biofilms from infected implant surfaces.

Methods In this prospective study, acute or early hematogenous periprosthetic joint infections (PJIs) will be treated with the modified proce...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Patients with periprosthetic joint infection (PJI) that will be treated with a debridement, antibiotics, and implant retention (DAIR) procedure
  • Exclusion Criteria:
  • • When a DAIR procedure seems not beneficial in a PJI case.

Trial Officials

Lukas K Kriechbaumer, MD

Principal Investigator

Paracelsus Medical University

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Salzburg, , Austria

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0